Selected publications
2024
Lapucci C, Boccia VD, Clementi TD, Schiavi S, Benedetti L, Uccelli A, Novi G, Cellerino M, Inglese M. Brain lesion microstructure in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein disease. J Neuroimaging. 2024;34(4):459-465. DOI: 10.1111/jon.13218
Connolly L, Chatfield S, Freeman J, Salter A, Amato MP, Brichetto G, Chataway J, Chiaravalloti ND, Cutter G, DeLuca J, Dalgas U, Farrell R, Feys P, Filippi M, Inglese M, Meza C, Moore NB, Motl RW, Rocca MA, Sandroff BM, Feinstein A. Associations between fatigue impact and physical and neurobehavioural factors: An exploration in people with progressive multiple sclerosis. Mult Scler Relat Disord 2024;90:105798, DOI: 10.1016/j.msard.2024.105798
Boccia VD, Boffa G, Lapucci C, Costagli M, Bosisio L, Mancardi MM, Inglese M, Cellerino M. Lesion phenotyping based on magnetic susceptibility in pediatric multiple sclerosis. J Neuroimaging. 2024, DOI: 10.1111/jon.13221
Mancardi GL, Boffa G, Inglese M. Introduction to HSCT for neurologic diseases. Handb Clin Neurol. 2024;202:1-6. DOI: 10.1016/B978-0-323-90242-7.00001-8
Lapucci C., et al. Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study. Mult Scler. 2024; 30(9):1151-1162. DOI: 10.1177/13524585241266509
Tazza F, Boffa G, Schiavi S, Lapucci C, Piredda GF, Cipriano E, Zacà D, Roccatagliata L, Hilbert T, Kober T, Inglese M, Costagli M. Multiparametric Characterization and Spatial Distribution of Different MS Lesion Phenotypes. AJNR Am J Neuroradiol. 2024;45(8):1166-1174. DOI: 10.3174/ajnr.A8271
2023
Tazza F., Schiavi S., Leveraro E., Cellerino M., Boffa G., Ballerini S., Dighero M., Uccelli A., Sbragia E., Aluan K., Inglese M., Lapucci C., Clinical and radiological correlates of apathy in Multiple Slerosis, Mult Scler., 2023; 14, DOI: 10.1177/13524585231217918
Schiavi S., Palombo M., Zacà D., Tazza F., Lapucci C., Castellan L., Costagli M., Inglese M., Mapping tissue microstructure across the human brain on a clinical scanner with soma and neurite density image metrics, 2023, Human Brain Mapping; 44(13), 4792:4811, DOI: 10.1002/hbm.26416
Cellerino M., Schiavi S., Lapucci C., Sbragia E., Boffa G., Rolla-Bigliani C., Tonelli S., Boccia D., Bruschi N., Tazza F., Franciotta D., Inglese M., In-vivo characterization of macro- and microstructural injury of the subventricular zone in relapsing-remitting and progressive multiple sclerosis, 2023, Frontiers in Neuroscience; 17, 1112199, DOI: 10.3389/fnins.2023.1112199
Boffa G. et al, Hematopoietic Stem Cell Transplantation in People with Active Secondary Progressive Multiple Sclerosis, 2023, Neurology; 100(11), E1109:E1122, DOI: 10.1212/WNL.0000000000206750
Boccia V.D., Saitta L., Inglese M., Lapucci C., Cortical ischemic lesions from atrial myxoma as a mimic of disease activity in an RRMS antiCD20-treated patient, 2023, Multiple Sclerosis Journal, 29(13): 1688:1692, DOI: 0.1177/13524585231195356
Schiavetti I., Inglese M., et al. Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it?, 2023, European Journal of Neurology, DOI: 10.1111/ene.15830
Bouman P.M., Noteboom S., Nobrega Santos F.A., Beck E.S., Bliault G., Castellaro M., Calabrese M., Chard D.T., Eichinger P., Filippi M., Inglese M., Lapucci C., Marciniak A., Moraal B., Pinzon A.M., Mühlau M., Preziosa P., Reich D.S., Rocca M.A., Schoonheim M.M., Twisk J.W.R., Wiestler B., Jonkman L.E., Guttmann C.R.G., Geurts J.J.G., Steenwijk M.D., Multicenter Evaluation of AI-generated DIR and PSIR for Cortical and Juxtacortical Multiple Sclerosis Lesion Detection, 2023, Radiology, 307(2):e221425 DOI: 10.1148/radiol.221425
Inglese M., Amato M.P., Presymptomatic MS or radiologically isolated syndrome should be actively monitored and treated: Commentary, 2023, Multiple Sclerosis Journal, 29(7); 797-798, DOI: 10.1177/13524585231172941
2022
Schiavi S., Palombo M., Zacà D., Tazza F., Lapucci C., Castellan L., Inglese M. Dissecting brain grey and white matter microstructure: a novel clinical diffusion MRI protocol. Preprint Biorxiv. DOI: 10.1101/2022.04.08.487640
Schiavi S., Inglese M. Advanced Diffusion MRI in Neurological Diseases: The Multiple Sclerosis Model. MAGNETOM Flash Siemens (80) 1/2022 siemens-healthineers.com/magnetom-world
Landi D., Grimaldi A., Bovis F., Ponzano M., Fantozzi R., Buttari F., Signoriello E., Lus G., Lucchini M., Mirabella M., Cellerino M., Inglese M., Cola G., Nicoletti C.G., Mataluni G., Centonze D., Marfia G.A. Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab. Neurol Neuroimmunol Neuroinflamm, 2022; 9(3):e1157. DOI: 10.1212/NXI.0000000000001157
Schiavi S., Azzari A., Mensi A., Graziano N., Daducci A., Bicego M., Inglese M., Petracca M. Classification of multiple sclerosis patients based on structural disconnection: A robust feature selection approach. J Neuroimaging. 2022; 32(4), 647:655; DOI: 10.1111/jon.12991
Pontillo G., Penna S., Cocozza S., Quarantelli M., Gravina M., Lanzillo R., Marrone S., Costabile T., Inglese M., Morra V.B., Riccio D., Elefante A., Petracca M., Sansone C., Brunetti A. Stratification of multiple sclerosis patients using unsupervised machine learning: a single-visit MRI-driven approach. Eur Radiol. 2022; 32(8):5382-53913, DOI: 10.1007/s00330-022-08610-z
2021
Palmeri S., Ponzano M., Ivaldi F., Signori A., Lapucci C., Casella V., Ferrò M.T., Vigo T., Inglese M., Mancardi G.L., Uccelli A., Laroni A. Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational Study. CNS Drugs. 36(1):83-962021, DOI: 10.1007/s40263-021-00875-0
Massarotti C., Sbragia E., Gazzo I., Stigliani S., Inglese M., Anserini P. Effect of Multiple Sclerosis and Its Treatments on Male Fertility: Cues for Future Research. J Clin Med. 2021; 10(22):5401, DOI: 10.3390/jcm10225401
Sormani M.P., Schiavetti I., Carmisciano L., Cordioli C., Filippi M., Radaelli M., Immovilli P., Capobianco M., De Rossi N., Brichetto G., Cocco E., Scandellari C., Cavalla P., Pesci I., Zito A., Confalonieri P., Marfia G.A., Perini P., Inglese M., Trojano M., Brescia Morra V., Tedeschi G., Comi G., Battaglia M.A., Patti F., Salvetti M. MuSC-19 Study Group. COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context. Neurol Neuroimmunol Neuroinflamm. 2021; 9(1):e1105, DOI: 10.1212/NXI.0000000000001105
Feinstein A., Amato M.P., Brichetto G., Chataway J., Chiaravalloti N.D., Cutter G., Dalgas U., DeLuca J., Farrell R., Feys P., Filippi M., Freeman J., Inglese M., Meza C., Motl R., Rocca M.A., Sandroff B.M., Salter A. CogEx Research Team. The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experience. J Neurol. 2021; 269(4):1758-1763, DOI: 10.1007/s00415-021-10881-3
Bergamaschi R., Ponzano M., Schiavetti I., Carmisciano L., Cordioli C., Filippi M., Radaelli M., Immovilli P., Capobianco M., De Rossi N., Brichetto G., Cocco E., Scandellari C., Cavalla P., Pesci I., Zito A., Confalonieri P., Marfia G.A., Perini P., Inglese M., Trojano M., Brescia Morra V., Pisoni E., Tedeschi G., Comi G., Battaglia M.A., Patti F., Salvetti M., Sormani M.P. MuSC-19 study group. The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis. Eur J Neurol. 2021; 29(2):535-542, DOI: 10.1111/ene.15167
Petracca M., Cutter G., Cocozza S., Freeman L., Kangarlu J., Margoni M., Moro M., Krieger S., El Mendili M.M., Droby A., Wolinsky J.S., Lublin F., Inglese M. Cerebellar pathology and disability worsening in relapsing-remitting multiple sclerosis: a retrospective analysis from the CombiRx trial. Eur J Neurol. 2021, 29(2):515:521, DOI:10.1111/ene.15157
Sandroff B.M., Motl R.W., Amato M.P., Brichetto G., Chataway J., Chiaravalloti N.D., Cutter G.R., Dalgas U., DeLuca J., Farrell R., Feys P., Filippi M., Freeman J., Inglese M., Meza C., Rocca M.A., Salter A., Feinstein A. Cardiorespiratory fitness and free-living physical activity are not associated with cognition in persons with progressive multiple sclerosis: Baseline analyses from the CogEx study. Mult Scler. 2021; 28(7):1091-1100, DOI: 10.1177/13524585211048397
Sormani MP, Inglese M, Schiavetti I, Carmisciano L, Laroni A, Lapucci C, Da Rin G, Serrati C, Gandoglia I, Tassinari T, Perego G, Brichetto G, Gazzola P, Mannironi A, Stromillo ML, Cordioli C, Landi D, Clerico M, Signoriello E, Frau J, Ferrò MT, Di Sapio A, Pasquali L, Ulivelli M, Marinelli F, Callari G, Iodice R, Liberatore G, Caleri F, Repice AM, Cordera S, Battaglia MA, Salvetti M, Franciotta D, Uccelli A; CovaXiMS study group on behalf of the Italian Covid-19 Alliance in MS. Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies. EBioMedicine. 2021, 72:103581, DOI: 10.1016/j.ebiom.2021.103581
Cellerino M., Boffa G., Lapucci C., Tazza F., Sbragia E., Mancuso E., Bruschi N., Minguzzi S., Ivaldi F., Poirè I., Laroni A., Mancardi G., Capello E., Uccelli A., Novi G., Inglese M. Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis. Neurotherapeutics. 2021; 18(4):2579-2588, DOI: 10.1007/s13311-021-01104-8
Morgello S., Buyukturkoglu K., Murray J., Veenstra M., Berman J.W., Byrd D., Inglese M. MR spectroscopy and diffusion imaging in people with human immunodeficiency virus: Relationships to clinical and immunologic findings. J Neuroimaging, 2021; ; 32(1):158-170, DOI: : 10.1111/jon.12931
Ferraro D., Iaffaldano P., Guerra T., Inglese M., Capobianco M., Brescia Morra V., Zaffaroni M., Mirabella M., Lus G., Patti F., Cavalla P., Cellerino M., Malucchi S., Pisano E., Vitetta F., Paolicelli D., Sola P., Trojano M; Italian MS Register. Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration. J Neurol. 2021; 269(3):1463-1469, DOI: 10.1007/s00415-021-10708-1
Chisari CG, Comi G, Filippi M, Paolicelli D, Iaffaldano P, Zaffaroni M, Brescia Morra V, Cocco E, Marfia GA, Grimaldi LM, Inglese M, Bonavita S, Lugaresi A, Salemi G, De Luca G, Cottone S, Conte A, Sola P, Aguglia U, Maniscalco GT, Gasperini C, Ferrò MT, Pesci I, Amato MP, Rovaris M, Solaro C, Lus G, Maimone D, Bergamaschi R, Granella F, Di Sapio A, Bertolotto A, Totaro R, Vianello M, Cavalla P, Bellantonio P, Lepore V, Patti F; Italian MS Register Study Group. PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study. J Neurol. 2021; 269(2):933-944, DOI: 10.1007/s00415-021-10676-6
Landi D., Signori A., Cellerino M., Fenu G., Nicoletti C.G., Ponzano M., Mancuso E., Fronza M., Ricchiuto M.E., Boffa G., Inglese M., Marfia G.A., Cocco E., Frau J. What happens after fingolimod discontinuation? A multicentre real-life experience. J Neurol. 2021; 269(2): 796-804, DOI:10.1007/s00415-021-10658-8
Bommarito G., Tarun A., Farouj Y., Preti M.G., Petracca M., Droby A., El Mendili M.M., Inglese M., Van De Ville D. Altered anterior default mode network dynamics in progressive multiple sclerosis. Mult Scler 2021; DOI:10.1177/13524585211018116
Iaffaldano P, Lucisano G, Caputo F, Paolicelli D, Patti F, Zaffaroni M, Brescia Morra V, Pozzilli C, De Luca G, Inglese M, Salemi G, Maniscalco GT, Cocco E, Sola P, Lus G, Conte A, Amato MP, Granella F, Gasperini C, Bellantonio P, Totaro R, Rovaris M, Salvetti M, Torri Clerici VLA, Bergamaschi R, Maimone D, Scarpini E, Capobianco M, Comi G, Filippi M, Trojano M; Italian MS Register. Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies. Ther Adv Neurol Disord. 2021 14:17562864211019574. DOI: 10.1177/17562864211019574
Droby A., Pelosin E., Putzolu M., Bommarito G., Marchese R., Mazzella L., Avanzino L., Inglese M. A Multimodal Imaging Approach Demonstrates Reduced Midbrain Functional Network Connectivity Is Associated With Freezing of Gait in Parkinson's Disease. Front Neurol. 2021; 12:583593. DOI: 10.3389/fneur.2021.583593
Baroncini D, Simone M, Iaffaldano P, Brescia Morra V, Lanzillo R, Filippi M, Romeo M, Patti F, Chisari CG, Cocco E, Fenu G, Salemi G, Ragonese P, Inglese M, Cellerino M, Margari L, Comi G, Zaffaroni M, Ghezzi A; Italian MS registry. Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis. JAMA Neurol. 2021;78(6):726-735. DOI: 10.1001/jamaneurol.2021.1008
Sbragia E., Colombo E., Pollio C., Cellerino M., Lapucci C., Inglese M., Mancardi G., Boffa G. Embracing resilience in multiple sclerosis: a new perspective from COVID-19 pandemic. Psychol Health Med. 2021; DOI: 10.1080/13548506.2021.1916964
Carotenuto A, Scandurra C, Costabile T, Lavorgna L, Borriello G, Moiola L, Inglese M, Trojsi F, Petruzzo M, Ianniello A, Nozzolillo A, Cellerino M, Boffa G, Rosa L, Chiodi A, Servillo G, Moccia M, Bonavita S, Filippi M, Petracca M, Brescia Morra V, Lanzillo R. Physical Exercise Moderates the Effects of Disability on Depression in People with Multiple Sclerosis during the COVID-19 Outbreak. J Clin Med. 2021 ;10(6):1234. DOI: 10.3390/jcm10061234
Lavorgna L., Brigo F., Esposito S., Abbadessa G., Sparaco M., Lanzillo R., Moccia M., Inglese M., Bonfanti L., Trojsi F., Spina E., Russo A., De Micco P., Clerico M., Tedeschi G., Bonavita S. Public Engagement and Neurology: An Update. Brain Sci. 2021;11(4):429. DOI: 10.3390/brainsci11040429
Zackowski K.M., Freeman J., Brichetto G., Centonze D., Dalgas U., DeLuca J., Ehde D., Elgott S., Fanning V., Feys P., Finlayson M., Gold S.M., Inglese M., Marrie R.A., Ploughman M., Sang C.N., Sastre-Garriga J., Sincock C., Strum J., van Beek J., Feinstein A. Prioritizing progressive MS rehabilitation research: A call from the International Progressive MS Alliance. Mult. Scler. 2021; 27(7):989-1001. DOI: 10.1177/1352458521999970
Massarotti C., Sbragia E., Boffa G., Vercelli C., Zimatore G.B., Cottone S., Frau J., Raiola A., Varaldo R., Mancardi G., Inglese M., Anserini P. Menstrual cycle resumption and female fertility after autologous hematopoietic stem cell transplantation for multiple sclerosis. Mult Scler. 2021; 27(13):2103-07, DOI: 10.1177/13524585211000616
Ferraro P.M., Cabona C., Meo G., Rolla-Bigliani C., Castellan L., Pardini M., Inglese M., Caponnetto C., Roccatagliata L. Age at symptom onset influences cortical thinning distribution and survival in amyotrophic lateral sclerosis. Neuroradiology. 2021 , 63(9):1481-1487, DOI: 10.1007/s00234-021-02681-3
Bommarito G., Putzolu M., Avanzino L., Cosentino C., Botta A., Marchese R., Inglese M., Pelosin E. Functional Correlates of Action Observation of Gait in Patients with Parkinson's Disease. Neural Plast. 2020:8869201, DOI: 10.1155/2020/8869201
D'Amico E, Zanghì A, Romeo M, Cocco E, Maniscalco GT, Brescia Morra V, Paolicelli D, De Luca G, Galgani S, Amato MP, Salemi G, Inglese M, Confalonieri PA, Lus G, Avolio C, Gallo A, Vianello M, Onofrj M, Filippi M, Trojano M, Patti F. Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register. Neurotherapeutics. 2021; 18(2): 905-919, DOI: DOI: 10.1007/s13311-020-01001-6
Cucca A., Di Rocco A., Acosta I., Beheshti M., Berberian M., Bertisch H.C., Droby A., Ettinger T., Hudson T.E., Inglese M., Jung Y.J., Mania D.F., Quartarone A., Rizzo J.R., Sharma K., Feigin A., Biagioni M.C., Ghilardi M.F. Art therapy for Parkinson's disease. Parkinsonism Relat Disord. 2021; 84:148-154, DOI: 10.1016/j.parkreldis.2021.01.013
Sormani MP, De Rossi N, Schiavetti I, Carmisciano L, Cordioli C, Moiola L, Radaelli M, Immovilli P, Capobianco M, Trojano M, Zaratin P, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M; Musc-19 Study Group. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis. Ann Neurol. 2021;89(4):780-789. DOI: 10.1002/ana.26028
Boffa G, Massacesi L, Inglese M, Mariottini A, Capobianco M, Lucia M, Amato MP, Cottone S, Gualandi F, De Gobbi M, Greco R, Scimè R, Frau J, Zimatore GB, Bertolotto A, Comi G, Uccelli A, Signori A, Angelucci E, Innocenti C, Ciceri F, Repice AM, Sormani MP, Saccardi R, Mancardi G; Italian BMT-MS study group. Long-Term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis. Neurology. 2021; 96(8):e1215-e1226, DOI: 10.1212/WNL.0000000000011461
Cabona C., Ferraro P.M., Meo G., Roccatagliata L., Schenone A., Inglese M., Villani F., Caponnetto C. Predictors of self-perceived health worsening over COVID-19 emergency in ALS. Neurol Sci. 2021;42(4):1231-1236, DOI:10.1007/s10072-020-04997-z
Cellerino M., Priano L., Bruschi N., Boffa G., Petracca M., Novi G., Lapucci C., Sbragia E., Uccelli A., Inglese M. Relationship Between Retinal Layers Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple Sclerosis. J Neuroophthalmol. 2020; 41(3):329-334, DOI: 10.1097/WNO.0000000000001165
Battaglini D., Santori G., Chandraptham K., Iannuzzi F., Bastianello M., Tarantino F., Ball L., Giacobbe D.R., Vena A., Bassetti M., Inglese M., Uccelli A., Rocco P.R.M., Patroniti N., Brunetti I., Pelosi P., Robba C. Neurological Complications and Noninvasive Multimodal Neuromonitoring in Critically Ill Mechanically Ventilated COVID-19 Patients. Front Neurol. 2020 ;11:602114. DOI: 10.3389/fneur.2020.602114
Schiavi S., Petracca M., Sun P., Fleysher L., Cocozza S., El Mendili M.M., Signori A., Babb J.S., Podranski K., Song S.K., Inglese M. Non-invasive quantification of inflammation, axonal and myelin injury in multiple sclerosis. Brain. 2021;144(1):213-223. DOI: 10.1093/brain/awaa381
Iaffaldano P, Lucisano G, Patti F, Brescia Morra V, De Luca G, Lugaresi A, Zaffaroni M, Inglese M, Salemi G, Cocco E, Conte A, Ferraro D, Galgani S, Bergamaschi R, Pozzilli C, Salvetti M, Lus G, Rovaris M, Maniscalco GT, Logullo FO, Paolicelli D, Achille M, Marrazzo G, Lovato V, Comi G, Filippi M, Amato MP, Trojano M; Italian MS Register. Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors. Mult Scler. 2021 ;27(3):430-438, DOI: 10.1177/1352458520974366
2020
Koudriavtseva T, Stefanile A, Fiorelli M, Lapucci C, Lorenzano S, Zannino S, Conti L, D'Agosto G, Pimpinelli F, Di Domenico EG, Mandoj C, Giannarelli D, Donzelli S, Blandino G, Salvetti M, Inglese M. Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-Remitting Multiple Sclerosis. Front Immunol. 2020; 11:548604. DOI: 10.3389/fimmu.2020.548604
Bruschi N., Boffa G., Inglese M. Ultra-high-field 7-T MRI in multiple sclerosis and other demyelinating diseases: from pathology to clinical practice. Eur Radiol Exp. 2020;4(1):59, DOI: 10.1186/s41747-020-00186-x
Petracca M., El Mendili M.M., Moro M., Cocozza S., Podranski K., Fleysher L., Inglese M. Laminar analysis of the cortical T1/T2-weighted ratio at 7T. Neurol Neuroimmunol Neuroinflamm. 2020;7(6):e900, DOI: 10.1212/NXI.0000000000000900
Tecchio F., Bertoli M., Gianni E., L'Abbate T., Sbragia E., Stara S., Inglese M. Parietal dysfunctional connectivity in depression in multiple sclerosis. Mult Scler. 2021;27(9):1468-1469. DOI: 10.1177/1352458520964412
Lepore V, Bosetti C, Santucci C, Iaffaldano P, Trojano M, Mosconi P; Italian Multiple Sclerosis Register Centers Group, the Scientific Committee of Italian SM Register. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register. Eur J Neurol. 2021;28(2):567-578. DOI: 10.1111/ene.14589
Costabile T, Carotenuto A, Lavorgna L, Borriello G, Moiola L, Inglese M, Petruzzo M, Trojsi F, Ianniello A, Nozzolillo A, Cellerino M, Boffa G, Rosa L, Servillo G, Moccia M, Bonavita S, Filippi M, Lanzillo R, Brescia Morra V, Petracca M. COVID-19 pandemic and mental distress in multiple sclerosis: Implications for clinical management. Eur J Neurol. 2020; 28(10):3375-3383, DOI: 10.1111/ene.14580
Saitta L., Molin A., Villani F., Insorsi A., Roccatagliata L., Inglese M., Bassetti M., Pelosi P., Castellan L., Gerevini S., Robba C., Patroniti N. Brain microvascular occlusive disorder in COVID-19: a case report. Neurol Sci. 2020;41(12):3401-3404. DOI: 10.1007/s10072-020-04795-7
Cellerino M., Bonavita S., Ferrero M., Inglese M., Boffa G. Severe disease activity in MS patients treated with cladribine after fingolimod withdrawal. J Neurol Sci. 2020; 418:117156. DOI: 10.1016/j.jns.2020.117156
Amatruda M., Petracca M., Wentling M., Inbar B., Castro K., Chen E.Y., Kiebish M.A., Edwards K., Inglese M., Casaccia P. Retrospective unbiased plasma lipidomic of progressive multiple sclerosis patients-identifies lipids discriminating those with faster clinical deterioration. Sci Rep. 2020; 10(1):15644. DOI: 10.1038/s41598-020-72654-8
Amato MP, Fonderico M, Portaccio E, Pastò L, Razzolini L, Prestipino E, Bellinvia A, Tudisco L, Fratangelo R, Comi G, Patti F, De Luca G, Brescia Morra V, Cocco E, Pozzilli C, Sola P, Bergamaschi R, Salemi G, Inglese M, Millefiorini E, Galgani S, Zaffaroni M, Ghezzi A, Salvetti M, Lus G, Florio C, Totaro R, Granella F, Vianello M, Gatto M, Di Battista G, Aguglia U, Logullo FO, Simone M, Lucisano G, Iaffaldano P, Trojano M. Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis. Brain. 2020;143(10):3013-3024. DOI:10.1093/brain/awaa251
Martino M., Magioncalda P., El Mendili M.M., Droby A., Paduri S., Schiavi S., Petracca M., Inglese M. Depression is associated with disconnection of neurotransmitter-related nuclei in multiple sclerosis. Mult Scler. 2021; 27(7):1102-1111. DOI: 10.1177/1352458520948214
Coccia A., Lapucci C., di Poggio M.B., Grazzini M., Inglese M., Finocchi C. A longitudinal clinical and MRI evaluation of the treatment with erenumab. Neurol Sci. 2020;41(Suppl 2):463-464. DOI: 10.1007/s10072-020-04660-7
Boffa G., Sbragia E., Raiola A.M., Varaldo R., Capello E., Gallo P., Granella F., Mancardi G., Inglese M. Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three cases. Mult Scler. 2021;27(7):1145-1148. DOI: 10.1177/1352458520914818
Chiaravalloti ND, Amato MP, Brichetto G, Chataway J, Dalgas U, DeLuca J, Meza C, Moore NB, Feys P, Filippi M, Freeman J, Inglese M, Motl R, Rocca MA, Sandroff BM, Salter A, Cutter G, Feinstein A; CogEx Research Team. The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis. J Neurol. 2021; 268(5):1598-1607. DOI: 10.1007/s00415-020-10160-7
Novi G, Bovis F, Fabbri S, Tazza F, Gazzola P, Maietta I, Currò D, Bruschi N, Roccatagliata L, Boffa G, Lapucci C, Pesce G, Cellerino M, Solaro C, Laroni A, Capello E, Mancardi G, Sormani M, Inglese M, Uccelli A. Tailoring B cell depletion therapy in MS according to memory B cell monitoring. Neurol Neuroimmunol Neuroinflamm. 2020; 7(5):e845. DOI: 10.1212/NXI.0000000000000845
Testa V., De Santis N., Scotto R., Pastorino C.E., Cellerino M., Olivari S., Morlacchi A.J., Inglese M., Uccelli A., Traverso C.E., Iester M. Neuroaxonal Degeneration in Patients With Multiple Sclerosis: An Optical Coherence Tomography and in Vivo Corneal Confocal Microscopy Study. Cornea. 2020; DOI: 10.1097/ICO.0000000000002396
Massarotti C., Inglese M., Anserini P. Fertility in multiple sclerosis patients: still many unanswered questions. Reprod Biomed Online. 2020;41(3):567. DOI: 10.1016/j.rbmo.2020.06.003
Signori A., Boffa G., Bovis F., Mariottini A., Repice A., Inglese M., Amato M.P., Mancardi G., Massacesi L., Saccardi R., Sormani M.P. Prevalence of disability improvement as a potential outcome for multiple sclerosis trials. Mult Scler. 2021 ;27(5):706-711. DOI: 10.1177/1352458520936236
Lebrun-Frenay C., Kantarci O., Siva A., Sormani M.P., Pelletier D., Okuda D.T. 10-year RISC study group on behalf of SFSEP, OFSEP. Radiologically Isolated Syndrome: 10-Year Risk Estimate of a Clinical Event. Ann Neurol. 2020; 88(2):407-417. DOI: 10.1002/ana.25799
Novi G., Rossi T., Pedemonte E., Saitta L., Rolla C., Roccatagliata L., Inglese M., Farinini D. Acute disseminated encephalomyelitis after SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. 2020 ;7(5):e797. DOI: 10.1212/NXI.0000000000000797
Droby A., Fleysher L., Petracca M., Podranski K., Xu J., Fabian M., Marjańska M., Inglese M. Lower cortical gamma-aminobutyric acid level contributes to increased connectivity in sensory-motor regions in progressive MS. Mult Scler Relat Disord. 2020; 43:102183. DOI: 0.1016/j.msard.2020.102183
Feinstein A, Amato MP, Brichetto G, Chataway J, Chiaravalloti N, Dalgas U, DeLuca J, Feys P, Filippi M, Freeman J, Meza C, Inglese M, Motl RW, Rocca MA, Sandroff BM, Salter A, Cutter G; CogEx Research Team. Study protocol: improving cognition in people with progressive multiple sclerosis: a multi-arm, randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic exercise (COGEx). BMC Neurol. 2020; 20(1):204. DOI: 10.1186/s12883-020-01772-7
Schiavi S., Petracca M., Battocchio M., El Mendili M.M., Paduri S., Fleysher L., Inglese M., Daducci A. Sensory-motor network topology in multiple sclerosis: Structural connectivity analysis accounting for intrinsic density discrepancy. Hum Brain Mapp. 2020; 41(11):2951-2963. DOI: 10.1002/hbm.24989
Fox E, Lovett-Racke AE, Gormley M, Liu Y, Petracca M, Cocozza S, Shubin R, Wray S, Weiss MS, Bosco JA, Power SA, Mok K, Inglese M. A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis. Mult Scler. 2021; 27(3):420-429. DOI: 10.1177/1352458520918375
Novi G., Mikulska M., Briano F., Toscanini F., Tazza F., Uccelli A., Inglese M. COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role? Mult Scler Relat Disord. 2020; 42:102120. DOI: 10.1016/j.msard.2020.102120
Cocozza S., Cosottini M., Signori A., Fleysher L., El Mendili M.M., Lublin F., Inglese M., Roccatagliata L. A clinically feasible 7-Tesla protocol for the identification of cortical lesions in Multiple Sclerosis. Eur Radiol. 2020; 30(8):4586-4594. DOI: 10.1007/s00330-020-06803-y
Boffa G., Bruschi N., Cellerino M., Lapucci C., Novi G., Sbragia E., Capello E., Uccelli A., Inglese M. Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population. CNS Drugs. 2020; 34(4):425-432. DOI: 10.1007/s40263-020-00714-8
Lapucci C., Romano N., Schiavi S., Saitta L., Uccelli A., Boffa G., Pardini M., Signori A., Castellan L., Inglese M., Roccatagliata L. Degree of microstructural changes within T1-SE versus T1-GE hypointense lesions in multiple sclerosis: relevance for the definition of "black holes". Eur Radiol. 2020; 30(7):3843-3851. DOI: 10.1007/s00330-020-06761-5
Cellerino M, Ivaldi F, Pardini M, Rotta G, Vila G, Bäcker-Koduah P, Berge T, Laroni A, Lapucci C, Novi G, Boffa G, Sbragia E, Palmeri S, Asseyer S, Høgestøl E, Campi C, Piana M, Inglese M, Paul F, Harbo HF, Villoslada P, Kerlero de Rosbo N, Uccelli A. Impact of treatment on cellular immunophenotype in MS: A cross-sectional study. Neurol Neuroimmunol Neuroinflamm. 2020;7(3):e693. DOI: 10.1212/NXI.0000000000000693
Rocchi G., Sterlini B., Tardito S., Inglese M., Corradi A., Filaci G., Amore M., Magioncalda P., Martino M. Opioidergic System and Functional Architecture of Intrinsic Brain Activity: Implications for Psychiatric Disorders. Neuroscientist. 2020; 26(4):343-358. DOI: 10.1177/1073858420902360
Novi G., Ivaldi F., Sbragia E., Mikulska M., Pesce G., Inglese M., Kerlero de Rosbo N., Uccelli A. Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS. Neurol Neuroimmunol Neuroinflamm. 2020; 7(3):e695. DOI: 10.1212/NXI.0000000000000695
Russo D., Martino M., Magioncalda P., Inglese M., Amore M., Northoff G. Opposing Changes in the Functional Architecture of Large-Scale Networks in Bipolar Mania and Depression. Schizophr Bull. 2020; 46(4):971-980. DOI: 10.1093/schbul/sbaa004
Magioncalda P., Martino M., Conio B., Lee H.C., Ku H.L., Chen C.J., Inglese M., Amore M., Lane T.J., Northoff G. Intrinsic brain activity of subcortical-cortical sensorimotor system and psychomotor alterations in schizophrenia and bipolar disorder: A preliminary study. Schizophr Res. 2020; 218:157-165. DOI: 10.1016/j.schres.2020.01.009
Iandolo R., Bommarito G., Falcitano L., Schiavi S., Piaggio N., Mancardi G.L., Casadio M., Inglese M. Position Sense Deficits at the Lower Limbs in Early Multiple Sclerosis: Clinical and Neural Correlates. Neurorehabil Neural Repair. 2020;34(3):260-270. DOI: 10.1177/1545968320902126
Inglese M. Conquering fear and accepting new challenges. EBioMedicine. 2020; 52:102642. DOI: 10.1016/j.ebiom.2020.102642
Martino M, Magioncalda P, Conio B, Capobianco L, Russo D, Adavastro G, Tumati S, Tan Z, Lee HC, Lane TJ, Amore M, Inglese M, Northoff G. Abnormal Functional Relationship of Sensorimotor Network With Neurotransmitter-Related Nuclei via Subcortical-Cortical Loops in Manic and Depressive Phases of Bipolar Disorder. Schizophr Bull. 2020; 46(1):163-174. DOI: 10.1093/schbul/sbz035
2019
El Mendili MM, Petracca M, Podranski K, Fleysher L, Cocozza S, Inglese M. SUITer: An Automated Method for Improving Segmentation of Infratentorial Structures at Ultra-High-Field MRI. J Neuroimaging. 2020; 30(1):28-39. DOI: 10.1111/jon.12672
George IC, El Mendili MM, Inglese M, Azevedo CJ, Kantarci O, Lebrun C, Siva A, Okuda DT, Pelletier D. Cerebellar volume loss in radiologically isolated syndrome. Mult Scler. 2021; 27(1):130-133. DOI: 10.1177/1352458519887346
Bauckneht M, Capitanio S, Raffa S, Roccatagliata L, Pardini M, Lapucci C, Marini C, Sambuceti G, Inglese M, Gallo P, Cecchin D, Nobili F, Morbelli S. Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers. EJNMMI Radiopharm Chem. 2019; 4(1):6. DOI: 10.1186/s41181-019-0058-3
Cellerino M, Cordano C, Boffa G, Bommarito G, Petracca M, Sbragia E, Novi G, Lapucci C, Capello E, Uccelli A, Inglese M. Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS. Neurol Neuroimmunol Neuroinflamm. 2019; 6(5):e596. DOI: 10.1212/NXI.0000000000000596
Lorenzano S., Inglese M., Koudriavtseva T. Editorial: Role of Coagulation Pathways in Neurological Diseases. Front Neurol. 2019; 10:791. DOI: 10.3389/fneur.2019.00791
Wentling M, Lopez-Gomez C, Park HJ, Amatruda M, Ntranos A, Aramini J, Petracca M, Rusielewicz T, Chen E, Tolstikov V, Kiebish M, Fossati V, Inglese M, Quinzii CM, Katz Sand I, Casaccia P. A metabolic perspective on CSF-mediated neurodegeneration in multiple sclerosis. Brain. 2019; 142(9):2756-2774. DOI: 10.1093/brain/awz201
Iandolo R, Carè M, Shah VA, Schiavi S, Bommarito G, Boffa G, Giannoni P, Inglese M, Mrotek LA, Scheidt RA, Casadio M. A two alternative forced choice method for assessing vibrotactile discrimination thresholds in the lower limb. Somatosens Mot Res. 2019; 36(2):162-170. DOI: 10.1080/08990220.2019.1632184
Lapucci C, Baroncini D, Cellerino M, Boffa G, Callegari I, Pardini M, Novi G, Sormani MP, Mancardi GL, Ghezzi A, Zaffaroni M, Uccelli A, Inglese M, Roccatagliata L. Different MRI patterns in MS worsening after stopping fingolimod. Neurol Neuroimmunol Neuroinflamm. 2019 ;6(4):e566. DOI: 10.1212/NXI.0000000000000566
Castro K, Ntranos A, Amatruda M, Petracca M, Kosa P, Chen EY, Morstein J, Trauner D, Watson CT, Kiebish MA, Bielekova B, Inglese M, Katz Sand I, Casaccia P. Body Mass Index in Multiple Sclerosis modulates ceramide-induced DNA methylation and disease course. EBioMedicine. 2019 May;43:392-410. DOI: 10.1016/j.ebiom.2019.03.087
Pardini M, Gualco L, Bommarito G, Roccatagliata L, Schiavi S, Solaro C, Mancardi G, Uccelli A, Capello E, Inglese M. CSF oligoclonal bands and normal appearing white matter periventricular damage in patients with clinically isolated syndrome suggestive of MS. Mult Scler Relat Disord. 2019; 31:93-96. DOI: 10.1016/j.msard.2019.03.027
Conio B., Martino M., Magioncalda P., Escelsior A., Inglese M., Amore M., Northoff G. Opposite effects of dopamine and serotonin on resting-state networks: review and implications for psychiatric disorders. Mol Psychiatry. 2020; 25(1):82-93. DOI: 10.1038/s41380-019-0406-4
Plantone D., Inglese M., Salvetti M., Koudriavtseva T. Corrigendum: A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis. Front Neurol. 2019; 9:1175. DOI: 10.3389/fneur.2019.00210
Makhani N, Lebrun C, Siva A, Narula S, Wassmer E, Brassat D, Brenton JN, Cabre P, Carra Dallière C, de Seze J, Durand Dubief F, Inglese M, Langille M, Mathey G, Neuteboom RF, Pelletier J, Pohl D, Reich DS, Ignacio Rojas J, Shabanova V, Shapiro ED, Stone RT, Tenembaum S, Tintoré M, Uygunoglu U, Vargas W, Venkateswaren S, Vermersch P, Kantarci O, Okuda DT, Pelletier D; Observatoire Francophone de la Sclérose en Plaques (OFSEP), Société Francophone de la Sclérose en Plaques (SFSEP), the Radiologically Isolated Syndrome Consortium (RISC) and the Pediatric Radiologically Isolated Syndrome Consortium (PARIS). Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome. Mult Scler J Exp Transl Clin. 2019;5(1):2055217319836664. DOI: 10.1177/2055217319836664
Lapucci C, Saitta L, Bommarito G, Sormani MP, Pardini M, Bonzano L, Mancardi GL, Gasperini C, Giorgio A, Inglese M, De Stefano N, Roccatagliata L. How much do periventricular lesions assist in distinguishing migraine with aura from CIS? Neurology. 2019; 92(15):e1739-e1744. DOI: 10.1212/WNL.0000000000007266
Plantone D., Inglese M., Salvetti M., Koudriavtseva T. A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis. Front Neurol. 2019; 9:1175. DOI: 10.3389/fneur.2018.01175
Meli R., Roccatagliata L., Capello E., Bruschi N., Uccelli A, Mancardi G, Inglese M, Pardini M. Ecological impact of isolated cognitive relapses in MS. Mult Scler. 2020; 26(1):114-117. DOI: 10.1177/1352458518813722
Conio B, Magioncalda P, Martino M, Tumati S, Capobianco L, Escelsior A, Adavastro G, Russo D, Amore M, Inglese M, Northoff G. Opposing patterns of neuronal variability in the sensorimotor network mediate cyclothymic and depressive temperaments. Hum Brain Mapp. 2019 Mar;40(4):1344-1352. DOI: 10.1002/hbm.24453
Sprooten E, O'Halloran R, Dinse J, Lee WH, Moser DA, Doucet GE, Goodman M, Krinsky H, Paulino A, Rasgon A, Leibu E, Balchandani P, Inglese M, Frangou S. Depth-dependent intracortical myelin organization in the living human brain determined by in vivo ultra-high field magnetic resonance imaging. Neuroimage. 2019; 185:27-34. DOI: 10.1016/j.neuroimage.2018.10.023
Zhang J, Magioncalda P, Huang Z, Tan Z, Hu X, Hu Z, Conio B, Amore M, Inglese M, Martino M, Northoff G. Altered Global Signal Topography and Its Different Regional Localization in Motor Cortex and Hippocampus in Mania and Depression. Schizophr Bull. 2019;45(4):902-910. DOI: 10.1093/schbul/sby138